These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33004741)
1. Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non-small cell lung cancer. Li M; Qin Y; Mei A; Wang C; Fan L J Cancer Res Ther; 2020 Sep; 16(5):1007-1013. PubMed ID: 33004741 [TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation Li M; Xu X; Qin Y; Zhang P; Shen C; Xia Q; Fan L J Cancer; 2021; 12(10):3057-3066. PubMed ID: 33854605 [No Abstract] [Full Text] [Related]
3. Survival after thermal ablation versus wedge resection for stage I non-small cell lung cancer < 1 cm and 1 to 2 cm: evidence from the US SEER database. Yim S; Lin WC; Liu JS; Yen MH Cancer Imaging; 2024 Jul; 24(1):91. PubMed ID: 38992679 [TBL] [Abstract][Full Text] [Related]
4. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database. Lin Y; Pan XB Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis. Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663 [TBL] [Abstract][Full Text] [Related]
7. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database. Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107 [No Abstract] [Full Text] [Related]
8. Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer. Sigel K; Lurslurchachai L; Bonomi M; Mhango G; Bergamo C; Kale M; Halm E; Wisnivesky J Lung Cancer; 2013 Nov; 82(2):266-70. PubMed ID: 24011407 [TBL] [Abstract][Full Text] [Related]
9. Postoperative chemotherapy significantly improves survival of elderly patients with stage IB-II non-small cell lung cancer: A population-based study. Liu W; Ma S; Shi P; Zhang Y; Li M Cancer Med; 2023 May; 12(10):11254-11263. PubMed ID: 37031456 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes. Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage. Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492 [TBL] [Abstract][Full Text] [Related]
13. Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database. Ni L; Lin G; Zhang Z; Sun D; Liu Z; Liu X BMC Pulm Med; 2022 Nov; 22(1):411. PubMed ID: 36357868 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare. Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615 [TBL] [Abstract][Full Text] [Related]
15. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study. Moon MH; Moon YK; Moon SW Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of Stage Ia Non-small Cell Lung Cancer in Patients: Comparison of Ablation and Sub-lobectomy]. Zhao H; Fan K; Wang H; Liu B; Li Y; Tao R; Wang Z; Zhang J; Fu J; Zhang G Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):613-622. PubMed ID: 34256899 [TBL] [Abstract][Full Text] [Related]
17. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Kates M; Swanson S; Wisnivesky JP Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736 [TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. Rajyaguru DJ; Borgert AJ; Smith AL; Thomes RM; Conway PD; Halfdanarson TR; Truty MJ; Kurup AN; Go RS J Clin Oncol; 2018 Feb; 36(6):600-608. PubMed ID: 29328861 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis. Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]